Radiosurgery for paraganglioma of the temporal bone

Head & Neck
Steven J FeigenbergP J Antonelli

Abstract

To report the outcome of patients with paraganglioma of the temporal bone treated with stereotactic radiosurgery at the University of Florida. Between January 1997 and June 1999, five patients with paraganglioma of the temporal bone were treated with Linac-based stereotactic radiosurgery at the University of Florida. The ages of the three female and two male patients were between 40 and 88 years (median, 49 years). Four patients were treated at initial presentation, and one had recurrent disease. Treatment volumes ranged from 4.9 cm3 to 18.4 cm3, with a mean of 10.84 cm3. The dose applied to the margin of the tumor varied from 12.5 to 15 Gy (median, 15 Gy). The treatment dose was specified to the 80% isodose shell in two cases and to the 70% isodose shell in three cases. The median follow-up time was 27 months, ranging from 14 to 50 months. One of four previously untreated patients had a relapse at the primary tumor site. Treatment failure occurred at the field margin 6 months after radiosurgery; the patient was subsequently treated with fractionated stereotactic radiotherapy and at the time of analysis had no evidence of disease, 21 months after initiation of salvage therapy. The patient treated at the time of recurrence after...Continue Reading

References

Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·S PowellC Harmer
Jun 1, 1992·Mayo Clinic Proceedings·S E SchildJ D Earle
Apr 1, 1992·Cancer·J M LarnerW C Constable
Oct 1, 1991·The Laryngoscope·M J O'LearyD E Brackmann
Feb 1, 1990·American Journal of Clinical Oncology·R Valdagni, M Amichetti
Aug 1, 1990·The Laryngoscope·J O BoyleS W Coulthard
Dec 1, 1990·Archives of Otolaryngology--head & Neck Surgery·D H KrausH M Tucker
Jan 1, 1989·The Annals of Otology, Rhinology, and Laryngology·H F BillerR Rosenfeld
Dec 1, 1989·International Journal of Radiation Oncology, Biology, Physics·R M PryzantJ D Easley
Dec 1, 1989·The Laryngoscope·T P Murphy, D E Brackmann
Nov 1, 1989·Surgical Neurology·W A Friedman, F J Bova
Nov 1, 1987·The Laryngoscope·J B KonefalC A Perez
Apr 1, 1988·International Journal of Radiation Oncology, Biology, Physics·M L WangB C Wen
Jun 1, 1988·The Laryngoscope·J D GreenB W Scheithauer
Feb 1, 1987·The Laryngoscope·J A CeceS C Parisier
Aug 1, 1988·Archives of Otolaryngology--head & Neck Surgery·K M HodgeL J Peters
Mar 1, 1986·Journal of Neurosurgery·F B MeyerB W Pearson
Jun 1, 1994·International Orthopaedics·D LimbR Mannion
Aug 1, 1994·The Laryngoscope·J D GreenA De la Cruz
Mar 1, 1994·International Journal of Radiation Oncology, Biology, Physics·W M MendenhallF J Bova
Apr 1, 1994·The Laryngoscope·A C UrquhartG L Schechter
Nov 1, 1993·The Laryngoscope·C I WoodsC G Jackson
Jan 15, 1993·International Journal of Radiation Oncology, Biology, Physics·M E LinskeyL D Lunsford
Feb 1, 1995·The Laryngoscope·J L NettervilleP Childs
Jun 1, 1997·International Journal of Radiation Oncology, Biology, Physics·R L FooteS E Schild
Jul 31, 1998·Journal of Vascular Surgery·A WesterbandJ L Mills
Mar 17, 1999·International Journal of Radiation Oncology, Biology, Physics·S R MabantaF J Bova
Mar 26, 1999·Head & Neck·D E EiseleB J Gantz
Oct 28, 1999·Acta neurochirurgica·S EustacchioG Pendl
Jan 26, 2000·The Laryngoscope·J A JordanC A Giller
Jun 6, 2000·International Journal of Radiation Oncology, Biology, Physics·S L MeeksF J Bova
Jan 1, 1996·Skull Base Surgery·M GjuricM E Wigand
Jan 1, 1995·Skull Base Surgery·W M MendenhallR R Million

❮ Previous
Next ❯

Citations

May 11, 2005·Familial Cancer·C C BoedekerJ Schipper
Feb 10, 2012·Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India·Sampath Chandra PrasadKishore Chandra Prasad
Jan 19, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Arturo Navarro MartínDaniel Pieper
Dec 18, 2007·Neurosurgical Focus·Gordon LiMichael Lim
Aug 27, 2004·Neurosurgical Focus·Michael LimSteven D Chang
Aug 27, 2004·Neurosurgical Focus·Oren N GottfriedWilliam T Couldwell
Mar 3, 2007·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Carlos SuárezJosé L Llorente
Sep 13, 2008·International Journal of Radiation Oncology, Biology, Physics·Sabrina T AstnerMarkus Essler
Jun 24, 2006·Neurosurgery Clinics of North America·Jonathan P S Knisely, Mark E Linskey
Jul 26, 2014·Cancer·Philip GilboWilliam M Mendenhall
May 10, 2006·International Journal of Radiation Oncology, Biology, Physics·Aaron J KrychMichael J Link
Jun 28, 2011·International Journal of Radiation Oncology, Biology, Physics·Zachary D GussMichael Lim
Jun 5, 2003·Technology in Cancer Research & Treatment·Michael LimSteven D Chang
Sep 20, 2007·Technology in Cancer Research & Treatment·Michael LimSteven D Chang
Dec 19, 2013·Surgical Neurology International·Emerson Magno de AndradeSalomon Benabou
Aug 21, 2018·Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·Scott ShapiroAdam Cassis
Aug 25, 2016·Cancer Control : Journal of the Moffitt Cancer Center·Kenneth Hu, Mark S Persky
Dec 20, 2012·Prague Medical Report·B A ErdoganM Paksoy
Feb 13, 2020·Acta neurochirurgica·Ungar LiorSpiegelmann Roberto
Nov 7, 2017·Otolaryngologic Clinics of North America·Mark Persky, Theresa Tran

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.